American Journal of Cardiology
Volume 103, Issue 6 , Pages 834-838 , 15 March 2009

Causes and Consequences of Nonpersistence With Heart Failure Medication

Received 7 August 2008 ,Revised 20 November 2008 ,Accepted 20 November 2008.

References 

  1. Gislason GG, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Buch P, et al Persistent use of evidence-based pharmacotherapy in HF is associated with improved outcomes. Circulation. 2007;116:737–744
  2. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19:1190–1196
  3. Varkey P, Cunningham J, Bisping DS. Improving medication reconciliation in the outpatient setting. Jt Comm J Qual Patient Saf. 2007;33:286–292
  4. Wu JR, Moser DK, Chung ML, Lennie TA. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with HF. J Card Fail. 2008;14:203–210
  5. Balkrishnan R, Jayawant S. Medication (Adherence research in populations: measurement issues and other challenges). Clin Ther. 2007;29:1180–1182
  6. MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA. Assessing medication adherence in the elderly: which tools to use in clinical practice?. Drugs Aging. 2005;22:231–255
  7. Mattke S, Jain AK, Sloss EM, Hirscher R, Bergamo G, O'Leary JF. Effect of disease management on prescription drug treatment: what is the right quality measure?. Dis Manag. 2007;10:91–100
  8. Fennie KP, Bova CA, Williams AB. Adjusting and censoring electronic monitoring device data (Implications for study outcomes). J Acquir Immune Defic Syndr. 2006;43(suppl 1):S88–S95
  9. McDonald K, Ledwidge M, Cahill J, Quigley P, Maurer B, Travers B, et al. HF management: multidisciplinary care has intrinsic benefit above the optimization of medical care. J Card Fail. 2002;8:142–148
  10. Ryder M, Murphy NF, McCaffrey D, O'Loughlin C, Ledwidge M, McDonald K. Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure. Eur J Heart Fail. 2008;10:267–272
  11. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with HF questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan (Pimobendan Multicenter Research Group). Am Heart J. 1992;124:1017–1025
  12. Norusis MJ. SPSS 13.0: Advanced Statistical Procedures Companion. Upper Saddle River, NJ: Prentice-Hall; 2004;
  13. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203–212
  14. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296:2563–2571
  15. Schweitzer RD, Head K, Dwyer JW. Psychological factors and treatment adherence behavior in patients with chronic HF. J Cardiovasc Nurs. 2007;22:76–83
  16. Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW. Patterns of pharmacotherapy in patients hospitalised for congestive HF. Eur J Heart Fail. 2003;5:195–200
  17. Ekman I, Andersson G, Boman K, Charlesworth A, Cleland JG, Poole-Wilson P, et al. Adherence and perception of medication in patients with chronic HF during a five-year randomised trial. Patient Educ Couns. 2006;61:348–353
  18. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, et al. Adherence to candesartan and placebo and outcomes in chronic HF in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005;366:2005–2011
  19. Morgan AL, Masoudi FA, Havranek EP, Jones PG, Peterson PN, Krumholz HM, et al. Difficulty taking medications, depression, and health status in HF patients. J Card Fail. 2006;12:54–60
  20. Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with HF. Br J Clin Pharmacol. 2005;60:183–193
  21. Koelling TM, Johnson ML, Cody RJ, Aaronson KD. Discharge education improves clinical outcomes in patients with chronic HF. Circulation. 2005;111:179–185

PII: S0002-9149(08)02116-4

doi: 10.1016/j.amjcard.2008.11.058

American Journal of Cardiology
Volume 103, Issue 6 , Pages 834-838 , 15 March 2009

Article Tools

* Image Usage & Resolution